Loading...

Sandy Wong, MD

TitleAssistant Professor
InstitutionUniversity of California San Francisco
DepartmentMedicine
Address400 Parnassus Avenue
San Francisco CA 94117
vCardDownload vCard

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ma X, Wong SW, Zhou P, Chaulagain CP, Doshi P, Klein AK, Sprague K, Kugelmass A, Toskic D, Warner M, Miller KB, Lee L, Varga C, Comenzo RL. Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth. Exp Hematol Oncol. 2018; 7:27. PMID: 30356940.
      View in: PubMed
    2. Wong SW, Hegenbart U, Palladini G, Shah GL, Landau HJ, Warner M, Toskic D, Jaccard A, Hansen T, Bladé J, Cibeira MT, Kastritis E, Dispenzieri A, Wechalekar A, Varga C, Schönland SO, Comenzo RL. Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p. Clin Lymphoma Myeloma Leuk. 2018 Jul 25. PMID: 30104177.
      View in: PubMed
    3. Lam C, Ferguson ID, Mariano MC, Lin YT, Murnane M, Liu H, Smith GA, Wong SW, Taunton J, Liu JO, Mitsiades CS, Hann BC, Aftab BT, Wiita AP. Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica. 2018 Apr 05. PMID: 29622655.
      View in: PubMed
    4. Tan M, Kalin-Hajdu E, Narayan R, Wong SW, Martin TG. Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma. J Oncol Pharm Pract. 2018 Jan 01; 1078155218785967. PMID: 30005587.
      View in: PubMed
    5. Wong SW, Toskic D, Warner M, Varga C, Moreno-Koehler A, Fein D, Fogaren T, Lee L, Oliver CM, Guthrie SD, Comenzo RL. Primary Amyloidosis With Renal Involvement: Outcomes in 77 Consecutive Patients at a Single Center. Clin Lymphoma Myeloma Leuk. 2017 Nov; 17(11):759-766. PMID: 28689003.
      View in: PubMed
    6. Wong SW, Larivee D, Warner M, Sprague KA, Fogaren T, Comenzo RL. Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy. Bone Marrow Transplant. 2017 06; 52(6):936-937. PMID: 28394371.
      View in: PubMed
    7. Sandy W. Wong, Melissa Warner, Alejandro Moreno-Koehler, Athena Kritharis, Michael E. Coyle, Deborah Black, Valerie Relias, Terry Fogaren, Nancy Cody Lyons, Francois Toka, Denise Larivee, Andrew M. Evens, Grace Kao, Kellie Sprague, Andreas K. Klein, Kenneth B. Miller, Raymond L. Comenzo.Toxicities, response and survival: Autologous stem cell transplantation for multiple myeloma over 25 years at a single center. Cancer Treatment and Research Communications. 2017; 11:1-5.
    8. Ma X, Zhou P, Wong SW, Warner M, Chaulagain C, Comenzo RL. siRNA targeting the ? light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases. Gene Ther. 2016 10; 23(10):727-733. PMID: 27383253.
      View in: PubMed
    9. Weiss BM, Wong SW, Comenzo RL. Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis. Blood. 2016 05 12; 127(19):2275-80. PMID: 26907632.
      View in: PubMed
    10. Wong SW, Comenzo RL. CD38 Monoclonal Antibody Therapies for Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2015 Nov; 15(11):635-45. PMID: 26443328.
      View in: PubMed
    11. Yuan Z, Liu X, Wong S, Machan JT, Chung MA. MUC1 Knockdown With RNA Interference Inhibits Pancreatic Cancer Growth. J Surg Res. 2009 Nov; 157(1):e39-46. PMID: 19482310.
      View in: PubMed
    12. Yuan Z, Wong S, Borrelli A, Chung MA. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. Biochem Biophys Res Commun. 2007 Oct 26; 362(3):740-6. PMID: 17764657.
      View in: PubMed
    13. Shaw MH, Boyartchuk V, Wong S, Karaghiosoff M, Ragimbeau J, Pellegrini S, Muller M, Dietrich WF, Yap GS. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc Natl Acad Sci U S A. 2003 Sep 30; 100(20):11594-9. PMID: 14500783; PMCID: PMC208803.